IM Cannabis (IMCC) Assets Average (2021 - 2026)
IM Cannabis' (IMCC) quarterly Assets Average came in at $20.0 million in Q1 2026, down 32.56% year-on-year from $29.7 million in Q1 2025, and down 27.16% quarter-over-quarter from $27.5 million in Q4 2025.
IM Cannabis (IMCC) Assets Average (2021 - 2026) Analysis & Trends
IM Cannabis' Assets Average history runs 6 years deep, the most recent figure standing at $20.0 million for Q1 2026.
- On a quarterly basis, Assets Average fell 32.56% year-over-year to $20.0 million in Q1 2026; TTM through Mar 2026 was $20.0 million, a 32.56% decrease from a year earlier, with the FY2025 full-year figure at $25.7 million, down 20.71% from the prior year.
- Assets Average declined to $20.0 million in Q1 2026 per IMCC's latest filing, from $27.5 million in the prior quarter.
- Across five years, Assets Average topped out at $224.9 million in Q1 2022 and bottomed at $20.0 million in Q1 2026.
- The 5-year median for Assets Average is $33.2 million (2024), against an average of $63.7 million.
- Across the five-year window, Assets Average surged 180.15% in 2022 and sank 80.73% in 2023, its largest moves.
- Year by year, Assets Average stood at $71.8 million in 2022, then slumped by 47.85% to $37.5 million in 2023, then declined by 18.88% to $30.4 million in 2024, then declined by 9.55% to $27.5 million in 2025, then decreased by 27.16% to $20.0 million in 2026.
- Per Business Quant, the three latest IMCC Assets Average figures stand at $20.0 million (Q1 2026), $27.5 million (Q4 2025), and $30.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 20.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.02 Mn |
| Dec 31, 2025 | 27.49 Mn |
| Sep 30, 2025 | 30.93 Mn |
| Jun 30, 2025 | 30.48 Mn |
| Mar 31, 2025 | 29.68 Mn |
| Dec 31, 2024 | 30.39 Mn |
| Sep 30, 2024 | 31.06 Mn |
| Jun 30, 2024 | 29.96 Mn |
| Mar 31, 2024 | 33.18 Mn |
| Dec 31, 2023 | 37.46 Mn |
| Sep 30, 2023 | 40.28 Mn |
| Jun 30, 2023 | 41.76 Mn |
| Mar 31, 2023 | 43.35 Mn |
| Dec 31, 2022 | 71.83 Mn |
| Sep 30, 2022 | 149.60 Mn |
| Jun 30, 2022 | 211.07 Mn |
| Mar 31, 2022 | 224.95 Mn |
| Dec 31, 2021 | 223.38 Mn |
| Sep 30, 2021 | 190.75 Mn |
| Jun 30, 2021 | 147.04 Mn |